Overview

DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors

Status:
NOT_YET_RECRUITING
Trial end date:
2027-07-30
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of DCSZ11 in combination with standard therapy in patients with advanced or metastatic solid tumors.
Phase:
PHASE1
Details
Lead Sponsor:
West China Hospital